What is the address of Cardiocenter Brussel?

The registered office of Cardiocenter Brussel is located at Hoezenbroekstraat 30, 1755 Pajottegem.

Is Cardiocenter Brussel still active?

Yes. According to the CBE (31 October 2026) Cardiocenter Brussel is active, legal situation “Normale toestand”, started on 9 November 2021.

Is Cardiocenter Brussel registered on Peppol?

Yes, Cardiocenter Brussel is registered on the Peppol network with ID 0208:0776994645.

What is the enterprise number of Cardiocenter Brussel?

The enterprise number of Cardiocenter Brussel is BE0776994645.

When was Cardiocenter Brussel founded?

Cardiocenter Brussel was founded on 9 November 2021.

Who are the directors of Cardiocenter Brussel?

According to the 2025 annual accounts, the directors of Cardiocenter Brussel are: Jielis Aart VISSER, Mohammad Ali MALAKZADEH, Najibullah RYSHTEN.

Is Cardiocenter Brussel a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 November 2021; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did Cardiocenter Brussel make in 2025?

Cardiocenter Brussel posted a profit after taxes of € 72 in financial year 2025.

What is the revenue of Cardiocenter Brussel?

As a small company, Cardiocenter Brussel is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 42,158.

Cardiocenter Brussel (Private Limited) - Pajottegem

Dossier Cardiocenter Brussel, printed on 31 October 2026 from databakkes.be/en/0776994645/cardiocenter-brussel. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Cardiocenter Brussel from Pajottegem, company number BE0776994645, closed financial year 2025 with a result of € 72 after tax. For that financial year Cardiocenter Brussel recorded a gross margin of € 42,158 and equity of € 3,000. Compared with financial year 2024, the result moved from € 139,187 to € 72. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 3,000

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 72

▼ € 139,114 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,120

▼ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 0.

People and assets in 2025

Vehicles and equipment

€ 602

▼ 55% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 143,007

▼ 18% vs 2024

€ 31,428 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 545

▼ 63% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -60,595 Gross margin 2022: € -60,595 First fiscal year in the series	€ -28,931 Gross margin 2023: € -28,931 ▲ € 31,664 vs 2022 (€ -60,595) Favourable step	€ 181,266 Gross margin 2024: € 181,266 ▲ € 210,197 vs 2023 (€ -28,931) Favourable step	€ 42,158 Gross margin 2025: € 42,158 ▼ 77% vs 2024 (€ 181,266) Unfavourable step	▼ 77%
Profit after taxes	€ -80,748 Profit after taxes 2022: € -80,748 First fiscal year in the series	€ -55,067 Profit after taxes 2023: € -55,067 ▲ € 25,681 vs 2022 (€ -80,748) Favourable step	€ 139,187 Profit after taxes 2024: € 139,187 ▲ € 194,254 vs 2023 (€ -55,067) Favourable step	€ 72 Profit after taxes 2025: € 72 ▼ € 139,114 vs 2024 (€ 139,187) Unfavourable step	▼ € 139,114
Equity	€ -81,192 Equity 2022: € -81,192 First fiscal year in the series	€ -136,259 Equity 2023: € -136,259 ▼ € 55,067 vs 2022 (€ -81,192) Unfavourable step	€ 2,928 Equity 2024: € 2,928 ▲ € 139,187 vs 2023 (€ -136,259) Favourable step	€ 3,000 Equity 2025: € 3,000 ▲ 2% vs 2024 (€ 2,928) Favourable step	▲ 2%
Total debts	€ 233,770 Total debts 2022: € 233,770 First fiscal year in the series	€ 397,691 Total debts 2023: € 397,691 ▲ 70% vs 2022 (€ 233,770) Unfavourable step	€ 239,361 Total debts 2024: € 239,361 ▼ 40% vs 2023 (€ 397,691) Favourable step	€ 202,939 Total debts 2025: € 202,939 ▼ 15% vs 2024 (€ 239,361) Favourable step	▼ 15%
Cash	-	€ 1,619 Cash 2023: € 1,619 First fiscal year in the series	€ 3,017 Cash 2024: € 3,017 ▲ 86% vs 2023 (€ 1,619) Favourable step	€ 2,120 Cash 2025: € 2,120 ▼ 30% vs 2024 (€ 3,017) Unfavourable step	▼ 30%
Land & buildings	€ 148,219 Land & buildings 2022: € 148,219 First fiscal year in the series	€ 169,956 Land & buildings 2023: € 169,956 ▲ 15% vs 2022 (€ 148,219) Unchanged	€ 149,657 Land & buildings 2024: € 149,657 ▼ 12% vs 2023 (€ 169,956) Unchanged	€ 129,359 Land & buildings 2025: € 129,359 ▼ 14% vs 2024 (€ 149,657) Unchanged	▼ 14%
Retained profit	€ -84,192 Retained profit 2022: € -84,192 First fiscal year in the series	€ -139,259 Retained profit 2023: € -139,259 ▼ € 55,067 vs 2022 (€ -84,192) Unfavourable step	€ -72 Retained profit 2024: € -72 ▲ € 139,187 vs 2023 (€ -139,259) Favourable step	€ 0 Retained profit 2025: € 0 ▲ € 72 vs 2024 (€ -72) Favourable step	▲ € 72
Bank debt	€ 161,352 Bank debt 2022: € 161,352 First fiscal year in the series	€ 207,194 Bank debt 2023: € 207,194 ▲ 28% vs 2022 (€ 161,352) Unfavourable step	€ 173,994 Bank debt 2024: € 173,994 ▼ 16% vs 2023 (€ 207,194) Favourable step	€ 143,007 Bank debt 2025: € 143,007 ▼ 18% vs 2024 (€ 173,994) Favourable step	▼ 18%
Balance sheet total	€ 152,578 Balance sheet total 2022: € 152,578 First fiscal year in the series	€ 261,432 Balance sheet total 2023: € 261,432 ▲ 71% vs 2022 (€ 152,578) Unchanged	€ 242,289 Balance sheet total 2024: € 242,289 ▼ 7% vs 2023 (€ 261,432) Unchanged	€ 205,939 Balance sheet total 2025: € 205,939 ▼ 15% vs 2024 (€ 242,289) Unchanged	▼ 15%

Key figures of Cardiocenter Brussel, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Cardiocenter Brussel?

What happened at Cardiocenter Brussel in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 72 (▼ € 139,114 vs 2024). Source: NBB ↗
Nov 9, 2021 New establishment in Pajottegem. KBO
2021 Jielis Aart VISSER became a director. NBB
2021 Mohammad Ali MALAKZADEH became a director. NBB
2021 Najibullah RYSHTEN became a director. NBB
Nov 9, 2021 Start of the company according to the CBE. KBO

In short

From € 80,748 loss in 2022 to € 72 profit in 2025.

Best year ever: 2024, with € 139,187 profit.

Original PDFs at the National Bank ↗

Management

Jielis Aart VISSER Mohammad Ali MALAKZADEH Najibullah RYSHTEN

Cardiocenter Brussel

DR MALAKZADEH,cardiologue.

CARDIOCENTER SINT-MARIA HALLE

Behind Cardiocenter Brussel are Jielis Aart VISSER, Mohammad Ali MALAKZADEH and Najibullah RYSHTEN. Mohammad Ali MALAKZADEH is also behind DR MALAKZADEH,cardiologue. and CARDIOCENTER SINT-MARIA HALLE.

Directors

According to the 2025 annual accounts

Jielis Aart VISSER

Director

since 2021

Mohammad Ali MALAKZADEH

Director

Also active at: DR MALAKZADEH,cardiologue., CARDIOCENTER SINT-MARIA HALLE

since 2021

Najibullah RYSHTEN

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Hoezenbroekstraat 30

1755 Pajottegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

GEBROEDERS VANDERHEYDEN

DR. JIELIS VISSER CARDIOLOOG

€ 184,021 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.994.645
VAT number: BE 0776.994.645
Registered office: Hoezenbroekstraat 30, 1755 Pajottegem
Names & denominations: Cardiocenter Brussel
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 November 2021
Peppol: Active · Active since 15 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

Cardiocenter Brussel

Warning lights

Financials

What happened to Cardiocenter Brussel?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions